(Q35793415)

English

Down-regulation of beta(1C) integrin in breast carcinomas correlates with high proliferative fraction, high histological grade, and larger size

scientific article published on January 2000

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Down-regulation of beta(1C) integrin in breast carcinomas correlates with high proliferative fraction, high histological grade, and larger size (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Patrick Maisonneuve

object named as

P Maisonneuve

3

0 references

author name string

M Manzotti

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

P Dell'Orto

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

M Fornaro

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

L R Languino

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

G Viale

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

language of work or name

0 references

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

The American Journal of Pathology

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

156

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

169-174

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868633

27 July 2018

Beta1C integrin in epithelial cells correlates with a nonproliferative phenotype: forced expression of beta1C inhibits prostate epithelial cell proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868633

27 July 2018

Down-regulation of beta 1C integrin, an inhibitor of cell proliferation, in prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868633

27 July 2018

Integrins: emerging paradigms of signal transduction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868633

27 July 2018

Inhibition of cell cycle progression by the alternatively spliced integrin beta 1C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868633

27 July 2018

Immunocytochemical localization of progesterone receptors in endocrine cells of the human pancreas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868633

27 July 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868633

27 July 2018

An alternative form of the integrin beta 1 subunit with a variant cytoplasmic domain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868633

27 July 2018

The novel structural motif Gln795-Gln802 in the integrin beta 1C cytoplasmic domain regulates cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964716-5

7 January 2021

Integrin laminin receptor profile of pulmonary squamous cell and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964716-5

7 January 2021

Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964716-5

7 January 2021

Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964716-5

7 January 2021

Classification of prostatic carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S0002-9440(10)64716-5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35793415&oldid=1610882141"